Literature DB >> 29530628

Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.

Michele Barone1, Endrit Shahini1, Andrea Iannone1, Maria Teresa Viggiani1, Valeria Corvace2, Mariabeatrice Principi1, Alfredo Di Leo3.   

Abstract

BACKGROUND: A critical flicker frequency (CFF) ≤39 Hz identifies cirrhotic patients with minimal hepatic encephalopathy (mHE) and predicts the risk of both overt hepatic encephalopathy (oHE) and mortality in patients with previous episodes of decompensation and/or oHE. AIMS: Herein, we evaluated the effectiveness of CFF in predicting the first episode of oHE and survival in cirrhotics who had never experienced an episode of oHE.
METHODS: Our cohort study of 134 patients and 150 healthy subjects were examined. A CFF > 39 Hz was considered normal and pathological when ≤39 Hz. The median follow up was 36 months.
RESULTS: At baseline, all controls had CFF > 39 Hz. Ninety-three patients had a CFF > 39 Hz and 41 had a CFF ≤ 39 Hz. The prevalence of CFF ≤ 39 Hz significantly increased with the progression of the Child-Pugh class (p = 0.003). Moreover, the risk of oHE was increased by CFF ≤ 39 (p < 0.001, by log-rank test) [HR = 7.57; CI(3.27-17.50); p < 0.0001, by Cox model] and ammonia [HR = 1.02 CI(1.01-1.03), p = 0.0009]. Both a CFF value ≤ 39 Hz and Child-Pugh class were independent predictors of mortality by Cox model [HR = 1.97; CI(1.01-3.95), p = 0.049; HR = 3.85 CI(1.68-8.83), p = 0.003].
CONCLUSIONS: CFF predicts the first episode of oHE in cirrhotics that had never experienced oHE, and predicts mortality risk. These findings suggest that cirrhotic patients should be routinely screened by CFF.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hepatonorm analyzer; Hyperammonemia; Liver decompensation; Neurophysiological test

Mesh:

Year:  2018        PMID: 29530628     DOI: 10.1016/j.dld.2018.01.133

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy.

Authors:  Agnieszka Stawicka; Magdalena Świderska; Justyna Zbrzeźniak; Natalia Sołowianowicz; Aleksandra Woszczenko; Robert Flisiak; Jerzy Jaroszewicz
Journal:  Clin Exp Hepatol       Date:  2021-02-02

3.  Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.

Authors:  Ting-Ting Jiang; Xiao-Li Liu; Yu-Yong Jiang; Xian-Bo Wang; Zhi-Yun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

Review 4.  Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use.

Authors:  Mads Kingo Guldberg Hansen; Kristoffer Kjærgaard; Lotte Lindgreen Eriksen; Lea Ladegaard Grønkjær; Anne Catrine Daugaard Mikkelsen; Thomas Damgaard Sandahl; Hendrik Vilstrup; Karen Louise Thomsen; Mette Munk Enok Lauridsen
Journal:  Metab Brain Dis       Date:  2022-02-01       Impact factor: 3.584

Review 5.  The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders.

Authors:  Giuseppe Losurdo; Fulvio Salvatore D'Abramo; Giuseppe Indellicati; Chiara Lillo; Enzo Ierardi; Alfredo Di Leo
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

Review 6.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

7.  Impaired Tactile Temporal Discrimination in Patients With Hepatic Encephalopathy.

Authors:  Moritz Lazar; Markus Butz; Thomas J Baumgarten; Nur-Deniz Füllenbach; Markus S Jördens; Dieter Häussinger; Alfons Schnitzler; Joachim Lange
Journal:  Front Psychol       Date:  2018-10-30

8.  Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests.

Authors:  Fabiola Sanchez-Meza; Aldo Torre; Lilia Castillo-Martinez; Sofia Sanchez-Roman; Luis Eduardo Morales-Buenrostro
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

9.  Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.

Authors:  Christian Labenz; Gerrit Toenges; Jörn M Schattenberg; Michael Nagel; Yvonne Huber; Jens U Marquardt; Joachim Labenz; Peter R Galle; Marcus-Alexander Wörns
Journal:  Clin Transl Gastroenterol       Date:  2020-06       Impact factor: 4.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.